IL-8: Biomarker to Differentiate Guillain-Barré Syndrome From CIDP
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Interleukin 8, a Biomarker to Differentiate Guillain-Barré Syndrome From CIDP
Neurol Neuroimmunol Neuroinflamm 2021 Jul 01;[EPub Ahead of Print], G Breville, AM Lascano, P Roux-Lombard, N Vuilleumier, PH LaliveFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.